Triple therapies plus different probiotics for Helicobacter pylori eradication

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 4, 2008, Pages 251-256

  Scaccianoce, G ^a   Zullo, Angelo ^b   Hassan, C ^b   Gentili, F ^b   Cristofari, F ^b   Cardinale, V ^b   Gigliotti, F ^b   Piglionica, D ^a   Morini, S ^b  

^a Umberto I Hospital   (Italy)

^b NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

Author keywords

Eradication; Helicobacter pylori; Probiotics; Therapy; Triple therapy

Indexed keywords

AMOXICILLIN; CARBON 13; CLARITHROMYCIN; LANSOPRAZOLE; PROBINUL; PROBIOTIC AGENT; REUFLOR; UREA;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG WITHDRAWAL; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INCIDENCE; LACTOBACILLUS REUTERI; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATIENT COMPLIANCE; PILOT STUDY; PROSPECTIVE STUDY; STOMACH BIOPSY; TASTE DISORDER; UREA BREATH TEST;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LACTOBACILLUS REUTERI; MALE; MIDDLE AGED; PILOT PROJECTS; PROBIOTICS; PROSPECTIVE STUDIES;

EID: 49449112940     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. VAIRA D, GATTA L, RICCI C, D'ANNA L, MIGLIOLI M. Helicobacter pylori: Diseases, tests and treatment. Dig Liver Dis 2001; 33: 788-794.
2. NARDONE G. Risk factor of cancer development in Helicobacter pylori gastritis. Dig Liver Dis 2000; 32(Suppl. 1): S190-192.
3. BAYERDORFFER E, MORGNER A. Gastric marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: Management of the disease. Dig Liver Dis 2000; 32: 192-194.
4. ANIBALE B, CAPURSO G, DELLE FAVE G. The stomach and iron deficiency anaemia: A forgotten link. Dig Liver Dis 2003; 35: 288-295.
5. LAHEU RJ, VAN ROSSUM LGM, JANSEN JB, STRAATMAN H, VERBEEK AL. Evaluation of treatment regimens to cure Helicobacter pylori infection. A meta-analysis. Aliment Pharmacol Ther 1999; 13: 857-864.
6. JANSSEN MJ, VAN OUEN AH, VERBEEK AL, JANSEN JB, DE BOER WA. A systematic comparison of triple therapies for treatment of Helicobacter pylori infection with proton pump inhibitor/ ranitidine bismuth citrate plus clarithromycin and either amoxycillin or a nitroimidazole. Aliment Pharmacol Ther 2001; 15: 613-624.
7. DE FRANCESCO V, ZULLO A, HASSAN C, DELLA VALLE N, PIETRINI L, MINENNA MF, WINN S, MONNO R, STOPPINO V, MORINI S, PANELLA C, IERARDI E. The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme: A prospective, randomised study. Dig Liver Dis 2004; 36: 322-326.
8. HUANG JQ, HUNT RH. Treatment after failure: The problem of "non-responders". Gut 1999; 45: 140-144.
9. GOTTELAND M, BRUNSER O, CRUCHET S. Systematic review: Are probiotics useful in controlling gastric colonization by Helicobacter pylori? Aliment Pharmacol Ther 2006; 23: 1077-1086.
10. HAMILTON-MILLER JM. The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int J Antimicrob Agents 2002; 22: 360-366.
11. MYLLYLUOMA E, KAJANDER K, MIKKOLA H, KYRÖNPALO S, RASMUSSEN M, KANKURI E, SIPPONEN P, VAPAATALO H, KORPELA R. Probiotic intervention decreases serum gastrin-17 in Helicobacter pylori infection. Dig Liver Dis 2007; 39: 516-523.
12. CRUCHET S, OBREGON MC, SALAZAR G, DIAZ E, GOTTELAND M. Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003; 19: 716-721.
13. GOTTELAND M, CRUCHET S. Suppressive effect of frequent ingestion of Lactobacillus johnsonii La1 on
14. Helicobacter pylori colonization in asymptomatic volunteers. J Antimicrob Chemother 2003; 51: 1317-1319.
15. PANTOFLICKOVA D, CORTHÉSY-THEULAZ I, DORTA G, STOLTE M, ISLER P, ROCHAT F, ENSLEN M, BLUM AL. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori-associated gastritis. Aliment Pharmacol Ther 2003; 18: 805-813.
16. CREMONINI F, DI CARO S, COVINO M, ARMUZZI A, GABRIELLI M, SANTARELLI L, NISTA EC, CAMMAROTA G, GASBARRINNI G, GASBARRINI A. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: A parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002; 97: 2744-2749.
17. DE BORTOLI N, LEONARDI G, CIANCIA E, MERLO A, BELLINI M, COSTA F, MUMOLO MG, RICCHIUTI A, CRISTIANI F, SANTI S, ROSSI M, MARCHI S. Helicobacter pylori eradication: A randomized, prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 2007; 102: 951-956.
18. MUKAI T, ASASAKA T, SATO E, MORI K, MATSUMOTO M, OHORI H. Inhibition of binding of Helicobacter pylori to the glycolipid receptors by probiotic Lactobacillus reuteri. FEMS Immunol Med Microbiol 2002; 32: 105-110.
19. IMASE K, TANAKA A, TOKUNAGA K, SUGANO H, ISHIDA H, TAKAHASHI S. Lactobacillus reuteri tablets suppress Helicobacter pylori infection: A double-blind randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi 2007; 81: 387-393.
20. SAGGIORO A, CAROLI M, PASINI M, BORTOLUZZI F, GIRARDI L, PILONE G. Helicobacter pylori eradication with Lactobacillus reuteri. A double-blind placebo-controlled study. Dig Liver Dis 2005; 37 (Suppl. 1): A88.
21. LIONETTI E, MINIELLO VL, CASTELLANETA SP, MAGISTÁ AM, DE CANIO A, MAUROGIOVANNI G, IERARDI E, CAVALLO L, FRANCAVILLA R. Lactobacillus reuteri therapy to reduce side-effects during anti- Helicobacter pylori treatment in children: A randomized placebo controlled trial. Aliment Pharmacol Ther 2006; 24: 1461-1468.
22. GRAHAM DY, DE BOER WA, TYTGAT GN. Choosing the best anti- Helicobacter pylori therapy: Effect of antimicrobial resistance. Am J Gastroenterol 1996; 91: 1072-1076.
23. GUARNER F, MALAGELADA JR. Gut flora in health and disease. Lancet 2003; 360: 512-519.
24. FLOCH MH. Bile salts, intestinal microflora and enterohepatic circulation. Dig Liver Dis 2002; 34: 54-57.
25. ADLER SN. The probiotic agent Escherichia coli M-17 has a healing effect in patients with IBS with proximal inflammation of the small bowel. Dig Liver Dis 2006; 38: 710-714.
26. TURSI, BRANDIMARTE G, GIORGETTI GM, ELISEI W. Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: A prospective, randomized, open-label study. J Clin Gastroenterol 2006; 40:312-316.
27. ZOCCO MA, DAL VERME LZ, CREMONINI F, PISCAGLIA AC, NISTA EC, CANDELLI M, NOVI M, RIGANTE D, CAZZATO IA, OJETTI V, ARMUZZI A, GASBARRINI G, GASBARRINI A. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 2006; 23:1567-1574.
28. MONTALTO M, MAGGIANO N, RICCI R, CURIGLIANO V, SANTORO L, DI NICUOLO F, VECCHIO FM, GASBARRINI A, GASBARRINI G. Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion 2004; 69: 225-228.
29. MONTALTO M, CURIGLIANO V, SANTORO L, VASTOLA M, CAMMAROTA G, MANNA R, GASBARRINI A, GASBARRINI G. Management and treatment of lactose malabsorption. World J Gastroenterol 2006; 12: 187-191.
30. REID G, BRUCE AW, FRASER N, HEINEMANN C, OWEN J, HENNING B. Oral probiotios can resolve urogenital infections. FEMS Immunol Med Microbiol 2001; 30: 49-52.
31. MIRAGLIA DEL GIUDICE M JR, DE LUCA MG, CAPRISTO C. Probiotics and atopic dermatitis. A new strategy in atopic dermatitis. Dig Liver Dis 2002; 34: S68-S71.
32. ZULLO A, HASSAN C, CAMPO SMA, MORINI S. Evolving therapy for Helicobacter pylori infection. Expert Opin Ther Patents 2004; 14: 1453-1464.
33. ZULLO A, DE FRANCESCO V, SCACCIANOCE G, HASSAN C, PANARESE A, PIGLIONICA D, PANELLA C, MORINI S, IERARDI E. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: A randomised, multicenter study. Dig Liver Dis 2005; 37: 496-500.
34. ZULLO A, DE FRANCESCO V, SCACCIANOCE G, MANES G, EFRATI C, HASSAN C, MACONI G, PIGLIONICA D, CANNAVIELLO C, PANELLA C, MORINI S, IERARDI E. Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicenter study. Dig Liver Dis 2007; 39: 806-810.
35. ZULLO A, HASSAN C, LORENZETTI R. A quintuple therapy for H. pylori eradication. Am J Gastroenterol 2007; 102:2601 (letter).
36. CASELLI M, ZULLO A, MACONI G, PARENTE F, ALVISI V, CASETTI T, SORRENTINO D, GASBARRINI G; WORKING GROUP OF THE CERVIA II MEETING. Cervia II Working Group Report 2006: Guidelines on diagnosis and treatment of Helicobacter pylori infection. Dig Liver Dis 2007; 39: 782-789.
37. ZAGARI RM, BIANCHI-PORRO G, FIOCCA R, GASBARRINI G, RODA E, BAZZOLI F. Comparison of one and two weeks of omeprazole, amoxicillin and clarithromyoin treatment for Helicobacter pylori eradication: The HYPER study. Gut 2007; 56: 475-479.
38. PAOLUZI P, IACOPINI F, CRISPINO P, NARDI F, BELLA A, RIVERA M, ROSSI P, GURNARI M, CARACCIOLO F, ZIPPI M, PICA R. 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: A large prospective single-center randomized study. Helicobacter 2006; 11: 562-568.